Named as a key player in 33 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Cell Based Immunotherapy | Pharmaceuticals | $16.6 Bn | 23% |
Named as key players in the same markets as Dendreon Pharmaceuticals LLC (number of shared markets).
AbbVie Inc.1 shared market
Bristol-Myers Squibb1 shared market
Gilead Sciences, Inc.1 shared market
Novartis AG1 shared market
Search all reports for Dendreon Pharmaceuticals LLC All companies